Myocet + Cyclophosphamide + Metformin Vs Myocet + Cyclophosphamide in 1st Line Treatment of HER2 Neg. Metastatic Breast Cancer Patients

Clinical trial NCT01885013 · COMPLETED

Trial details

NCT number: NCT01885013
Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Human Epidermal Growth Factor 2 Negative Carcinoma of Breast

Start date: 2010-09-01
Primary completion: 2015-05-01
Enrollment: 126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.